======= TXNDC17 ======= == Gene Information == * **Official Symbol**: TXNDC17 * **Official Name**: thioredoxin domain containing 17 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=84817|84817]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BRA2|Q9BRA2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TXNDC17&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TXNDC17|Open PubMed]] * **OMIM**: [[https://omim.org/entry/616967|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Disulfide reductase. May participate in various redox reactions through the reversible oxidation of its active center dithiol to a disulfide and catalyze dithiol-disulfide exchange reactions. Modulates TNF-alpha signaling and NF-kappa-B activation. Has peroxidase activity and may contribute to the elimination of cellular hydrogen peroxide. {ECO:0000269|PubMed:14607843, ECO:0000269|PubMed:14607844}. |DUF953| |protein-disulfide reductase activity| |peroxidase activity| |cellular oxidant detoxification| |cellular detoxification| |tumor necrosis factor-mediated signaling pathway| |detoxification| |cellular response to toxic substance| |cellular response to tumor necrosis factor| |response to tumor necrosis factor| |response to toxic substance| |cytokine-mediated signaling pathway| |oxidation-reduction process| |cellular response to cytokine stimulus| |response to cytokine| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-2.38| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|1.73| |[[:results:exp507|Monensin 0.3μM R08 exp507]]|1.73| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|1.77| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|1.95| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|2.18| |[[:results:exp26|Oligomycin-A 20μM R00 exp26]]|2.27| |[[:results:exp22|MLN-4924 2μM R00 exp22]]|2.34| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|2.37| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|2.89| ^Gene^Correlation^ |[[:human genes:h:hars|HARS]]|0.442| |[[:human genes:w:wdr24|WDR24]]|0.405| Global Fraction of Cell Lines Where Essential: 2/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|1/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|1/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5494 * **Expression level (log2 read counts)**: 4.73 {{:chemogenomics:nalm6 dist.png?nolink |}}